| Literature DB >> 34774558 |
Yu Pan1, Shirong Cao2, Andrew S Terker2, Jiaqi Tang2, Kensuke Sasaki2, Yinqiu Wang2, Aolei Niu2, Wentian Luo2, Xiaofeng Fan2, Suwan Wang2, Matthew H Wilson2, Ming-Zhi Zhang3, Raymond C Harris4.
Abstract
Following acute injury to the kidney, macrophages play an important role in recovery of functional and structural integrity, but organ fibrosis and progressive functional decline occur with incomplete recovery. Pro-resolving macrophages are characterized by increased cyclooxygenase 2 (COX-2) expression and this expression was selectively increased in kidney macrophages following injury and myeloid-specific COX-2 deletion inhibited recovery. Deletion of the myeloid prostaglandin E2 (PGE2) receptor, E-type prostanoid receptor 4 (EP4), mimicked effects seen with myeloid COX-2-/- deletion. PGE2-mediated EP4 activation induced expression of the transcription factor MafB in kidney macrophages, which upregulated anti-inflammatory genes and suppressed pro-inflammatory genes. Myeloid Mafb deletion recapitulated the effects seen with either myeloid COX-2 or EP4 deletion following acute kidney injury, with delayed recovery, persistent presence of pro-inflammatory kidney macrophages, and increased kidney fibrosis. Thus, our studies identified a previously unknown mechanism by which prostaglandins modulate macrophage phenotype following acute organ injury and provide new insight into mechanisms underlying detrimental kidney effects of non-steroidal anti-inflammatory drugs that inhibit cyclooxygenase activity. Published by Elsevier Inc.Entities:
Keywords: AKI; cyclooxygenase 2; macrophage polarization; renal fibrosis
Mesh:
Substances:
Year: 2021 PMID: 34774558 PMCID: PMC8741730 DOI: 10.1016/j.kint.2021.09.033
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612